Realbotix Valuation
Is XBOT.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of XBOT.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate XBOT.F's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate XBOT.F's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for XBOT.F?
Key metric: As XBOT.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is XBOT.F's PS Ratio? | |
|---|---|
| PS Ratio | 21.8x |
| Sales | US$974.45k |
| Market Cap | US$19.67m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 20.3x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does XBOT.F's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.4x | ||
TETA.A Teton Advisors | 2x | n/a | US$22.3m |
HGPI Horizon Group Properties | 1.2x | n/a | US$19.1m |
EQS Equus Total Return | 14.5x | n/a | US$16.0m |
STEC Santech Holdings | 0.1x | n/a | US$30.0m |
XBOT.F Realbotix | 21.8x | 126.7% | US$19.7m |
Price-To-Sales vs Peers: XBOT.F is expensive based on its Price-To-Sales Ratio (21.8x) compared to the peer average (4.4x).
Price to Sales Ratio vs Industry
How does XBOT.F's PS Ratio compare vs other companies in the US Capital Markets Industry?
Price-To-Sales vs Industry: XBOT.F is expensive based on its Price-To-Sales Ratio (21.8x) compared to the US Capital Markets industry average (3.5x).
Price to Sales Ratio vs Fair Ratio
What is XBOT.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 21.8x |
| Fair PS Ratio | 2.1x |
Price-To-Sales vs Fair Ratio: XBOT.F is expensive based on its Price-To-Sales Ratio (21.8x) compared to the estimated Fair Price-To-Sales Ratio (2.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
International Money Express
US$659.3m
Operates as an omnichannel money remittance services company in the United States, Latin America, Mexico, Central and South America, the Caribbean, Africa, and Asia.
IMXI
US$21.32
7D
2.2%
1Y
0.09%
Investor
SEK 911.2b
A private equity firm specializing in mature, middle market, buyouts and growth capital investments.
IVSB.F
SEK 27.00
7D
2.9%
1Y
31.6%
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
IX
JP¥107.62
7D
-0.2%
1Y
17.7%